FOSFOMYCIN POWDER FOR ORAL SOLUTION DIN 02489457
Status: Cancelled Pre Market
Holder: ENDO OPERATIONS LTD.
Molecule: FOSFOMYCIN (FOSFOMYCIN TROMETHAMINE)
Health Canada record
| Active ingredient(s) | FOSFOMYCIN (FOSFOMYCIN TROMETHAMINE) 3 G |
|---|---|
| Dosage form | Powder For Solution |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01XX01 FOSFOMYCIN |
| Original market date | |
| Current status date | 07-Jul-2023 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FOSFOMYCIN (FOSFOMYCIN TROMETHAMINE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02473801 | JAMP FOSFOMYCIN | JAMP PHARMA CORPORATION | Powder For Solution | FOSFOMYCIN (FOSFOMYCIN TROMETHAMINE) 3 G | Marketed |
| 02240335 | MONUROL | KNIGHT THERAPEUTICS INC. | Powder For Solution | FOSFOMYCIN (FOSFOMYCIN TROMETHAMINE) 3 G | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 22280 | 2019-06-13 | New Drug Submission (NDS) | LICENSING AGREEMENT BETWEEN TWO COMPANIES |